ABSTRACT Introduction and objective: For a long time, radical surgery was the standard treatment for cervical cancer. In earlystage disease, hysterectomy with lymphadenectomy was commonly performed, which forever precluded any procreative plans. The increasing number of newly-diagnosed cervical cancer cases among women of reproductive age has led to the development of fertility-preserving treatments and minimally invasive techniques. Review methods: The review outlines fertility-sparing treatment options for patients of childbearing age diagnosed with cervical cancer. PubMed and Google Scholar (2016–2024) were searched using the terms: cervical cancer, fertility sparing treatment, fertility preservation, trachelectomy, radical trachelectomy, neoadjuvant chemotherapy, cervical cancer treatment, conization and simple trachelectomy from 5 March – 28 March 2025. Original papers, literature review, case reports, randomized clinical trials and meta-analysis were included. Manuscripts not written in English were excluded excluded. Brief description of the state of knowledge: Depending on the stage of the cancer, options such as conization, trachelectomy, or neoadjuvant chemotherapy can help preserve fertility while avoiding radical procedures. The methods are evaluated for oncological outcomes, including metastasis and recurrence, and for reproductive outcomes, such as pregnancy. Summary: The review presents current fertility-sparing surgical methods as well as chemotherapeutic approaches used to preserve fertility in women undergoing treatment for cervical cancer, the outcomes and eligibility criteria. The growing clinical relevance of fertility preservation underscores its increasing role in individualized treatment planning for cervical cancer patients.